The 7 analysts offering 12-month price forecasts for Infinity Pharmaceuticals Inc have a median target of 9.00, with a high estimate of 14.00 and a low estimate of 4.00. The median estimate represents a +152.81% increase from the last price of 3.56.
The current consensus among 7 polled investment analysts is to Buy stock in Infinity Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.14
Reporting Date Nov 09
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.